IP Library Granted Patent US 8,802,600
Granted Patent B2
US 8,802,600 · App. 11/731,748 · Granted Aug 12, 2014

Articles having localized molecules disposed thereon and methods of producing same

Inventors: David R. Rank (Palo Alto, CA); Jeffery Wegener (Cupertino, CA); Jonas Korlach (Castro Valley, CA); Daniel Roitman (Menlo Park, CA); Yue Xu (Fremont, CA); John Lyle (Redwood Shores, CA); Stephen Turner (Menlo Park, CA); Paul Peluso (Hayward, CA); Geoff Otto (Santa Clara, CA); Ron Cicero (Palo Alto, CA)
Assignee: Pacific Biosciences of California, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,802,600
App. No.
11/731,748
Granted
Aug 12, 2014
Kind
B2
Abstract

Methods of producing substrates having selected active chemical regions by employing elements of the substrates in assisting the localization of active chemical groups in desired regions of the substrate. The methods may include optical, chemical and/or mechanical processes for the deposition, removal, activation and/or deactivation of chemical groups in selected regions of the substrate to provide selective active regions of the substrate.

Claims (20)

1. A zero mode waveguide array, comprising:

a plurality of zero mode waveguide cores disposed in a cladding layer, each core having a bottom reading surface;

wherein a plurality of zero mode waveguide cores in the array comprise an enzyme bound to the bottom surface;

wherein portions of the array other than the bottom surface of the cores are substantially free of the enzyme; and

wherein the cladding layer comprises a compound comprising one or more phosphonic acid groups.

2. The zero mode waveguide array of claim 1 , wherein the cladding layer is disposed on a silica based substrate.

3. The zero mode waveguide array of claim 1 , wherein the cladding comprises a metal or metal oxide.

4. The zero mode waveguide array of claim 1 , wherein the plurality of zero mode waveguide cores in the array have only a single active enzyme molecule bound to the bottom surface.

5. The zero mode waveguide array of claim 4 , wherein the enzyme comprises a polymerase enzyme.

6. The zero mode waveguide array of claim 1 , wherein the enzyme is bound to the bottom surface through one or more silanes.

7. The zero mode waveguide array of claim 1 , wherein the enzyme is bound to the bottom surface through a binding or coupling group.

8. The zero mode waveguide array of claim 7 , wherein the binding or coupling group comprises an antibody, an antibody fragment, avidin, biotin, a binding peptide, a lectin, or complementary nucleic acids.

9. The zero mode waveguide array of claim 1 , wherein the enzyme is bound to the bottom surface through biotin.

10. The zero mode waveguide array of claim 1 , wherein the enzyme is bound to the bottom surface through a phospholipid bilayer.

11. The zero mode waveguide array of claim 9 , wherein the enzyme is bound to the bottom surface through a biotin-PEG-silane.

12. The method of claim 1 , wherein the compound comprising one or more phosphonic acid groups is polyvinylphosphonic acid.

13. The method of claim 1 , wherein the compound comprising one or more phosphonic acid groups is selected from the group consisting of:

14. The method of claim 1 , wherein the compound comprising one or more phosphonic acid groups is selected from the group consisting of: 2-carboxyethyl phosphonic acid; amino tri (methylene phosphonic acid); 1-hydroxyethylidene -1,1,-diphosphonic acid; hexamethylenediaminetetra (methylenephosphonic acid); diethylenetriamine penta(methylene phosphonic acid); ethylenediamine tetra(methylene phosphonic acid); bis(hexamethylene triamine penta(methylenephosphonic acid)); 2-phosphonobutane - 1,2,4 - tricarboxylic acid; and monoethanloamine diphosphonate.

15. The method of claim 1 , wherein the compound comprising one or more phosphonic acid groups comprises an alkyl phosphonate.

16. The method of claim 1 , wherein the compound comprising one or more phosphonic acid groups is selected from the group consisting of: octyl phosphonic acid, decyl phosphonic acid, dodecyl phosphonic acid, hexadecyl phosphonic acid, octadecyl phosphonic acid, docosyl phosphonic acid, hydroxy-dodecyl phosphonic acid, hydroxy-undecenyl-phosphonic acid, and decanediylbis(phosphonic acid).

Assignments (4)
CONFIRMATORY LICENSE Recorded Sep 22, 2011
From: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (FORMERLY NANOFLUIDICS, INC.)
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026973/0490 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2010
From: CICERO, RONALD L.
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 024503/0565 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2009
From: CICERO, RONALD L
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 023130/0042 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2007
From: RANK, DAVID R.; WEGENER, JEFFERY; KORLACH, JONAS; ROITMAN, DANIEL; XU, YUE; LYLE, JOHN; TURNER, STEPHEN; PELUSO, PAUL; OTTO, GEOFF
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 019959/0372 →
Continuity (2)
Continuation In Part 11394352 · Mar 30, 2006
Related Publication 20080032301A1 · Feb 7, 2008